News
Lilly's BTK drug Jaypirca joins first-line options in US
Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA for its first frontline indication, but will it be reserved for later-line use?
News
Novo faces delay in US review of haemophilia drug
The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.
News
Bayer pledges $2.2bn to US manufacturing facility
Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.
News
NICE backs Sobi's Tryngolza for rare disease FCS
Patients in England and Wales with familial chylomicronaemia syndrome will soon have a new treatment option, as NICE backs Sobi's Tryngolza.
News
GLOBE model finalised, with narrowed scope and fewer savings
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
